ORIGINAL ARTICLE
Year : 2011 | Volume
: 4 | Issue : 2 | Page : 63--66
Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
Ahmed S Al-Hinai, Mohammed S Al-Abri
Department of Ophthalmology, Sultan Qaboos University Hospital, Oman
Correspondence Address:
Ahmed S Al-Hinai
Postal code 132, PO box 857, Al-Khod, Seeb, Muscat
Oman
Objective : To evaluate the efficacy and safety of half-fluence photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC) in Omani population.
Materials and Methods : A Retrospective chart review of all patients with chronic CSC treated with half-fluence PDT from November 2009 to December 2010 was carried out. Recorded parameters included best-corrected visual acuity, findings of clinical examination, results of fluorescein angiography and optical coherence tomography at baseline and during follow-up visits after treatment.
Results : Six eyes (of five Omani patients) with chronic CSC, of at least 9 months duration, were treated with half-fluence PDT. All eyes showed a complete resolution of CSC within 1 month following treatment. Four eyes showed visual improvement and two had unchanged stable vision. No complications from the treatment were noticed during the follow-up visits.
Conclusion : Half-fluence PDT to treat chronic CSC in Omani population is a promising treatment that results in both structural and functional improvement.
How to cite this article:
Al-Hinai AS, Al-Abri MS. Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series.Oman J Ophthalmol 2011;4:63-66
|
How to cite this URL:
Al-Hinai AS, Al-Abri MS. Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series. Oman J Ophthalmol [serial online] 2011 [cited 2023 Mar 25 ];4:63-66
Available from: https://www.ojoonline.org/article.asp?issn=0974-620X;year=2011;volume=4;issue=2;spage=63;epage=66;aulast=Al-Hinai;type=0 |
|
